ADVFN US – Market Content Editor
-

BofA: Gold’s Decline Tied to CTA Selling Pressure
The recent slide in gold prices has been partly attributed to selling by trend-following funds, according to Bank of America (BofA). Analysts noted that commodity trading advisors (CTAs) “continued to unwind gold longs as the yellow metal declined for the second straight week.” “Our more risk-averse models have already stopped out of their gold longs…
-

Microsoft Gains U.S. Approval to Export Nvidia AI Chips to the UAE — FT
Microsoft (NASDAQ:MSFT) has received authorization from the U.S. government to export advanced Nvidia (NASDAQ:NVDA) AI chips to the United Arab Emirates, marking a key step in the company’s expansion across the Middle East, according to the Financial Times. Brad Smith, Microsoft’s president, confirmed that in September, the company became “the first company to receive a…
-

Bruker Shares Dip 3% After Q3 Beat but Weaker Full-Year Outlook
Bruker Corporation (NASDAQ:BRKR) reported third-quarter 2025 earnings that topped expectations, but its shares fell 3.2% in premarket trading after the company issued a full-year forecast that disappointed investors. The scientific instruments manufacturer posted adjusted earnings of $0.45 per share, surpassing the analyst consensus of $0.33. Revenue came in at $860.5 million, ahead of expectations of…
-

Benitec Biopharma Shares Surge 20% After FDA Grants Fast Track Status for OPMD Gene Therapy
Benitec Biopharma Inc. (NASDAQ:BNTC) shares soared 20% on Monday after the biotech company announced positive interim results from its ongoing Phase 1b/2a clinical trial of BB-301 and confirmed that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the therapy. The clinical-stage gene therapy company reported that all six patients in…
-

IDEXX Laboratories Shares Surge 7% After Beating Q3 Estimates on Strong Diagnostic Demand
IDEXX Laboratories (NASDAQ:IDXX) shares jumped 7.2% on Monday after the animal health diagnostics leader reported third-quarter earnings and revenue that topped Wall Street expectations, supported by solid global demand for its advanced veterinary testing products. The company posted adjusted earnings of $3.22 per share, above analyst estimates of $3.14, while revenue rose 13% year over…
-

Cipher Mining Shares Jump 15% After Securing $5.5 Billion AI Infrastructure Lease with AWS
Cipher Mining Inc. (NASDAQ:CIFR) shares surged 15% on Monday after the company revealed a landmark $5.5 billion, 15-year lease agreement with Amazon Web Services (NASDAQ:AMZN) to supply turnkey space and power capacity tailored for AI workloads. Under the agreement, Cipher will deliver 300 megawatts of capacity in 2026, featuring both air and liquid cooling systems.…
-

Pediatrix Medical Group Shares Jump Over 10% After Strong Q3 Earnings Beat Expectations
Pediatrix Medical Group, Inc. (NYSE:MD) shares surged 10.4% on Monday after the physician services provider reported third-quarter results that comfortably exceeded Wall Street estimates, boosted by robust collection activity and an increase in patient acuity levels. The company posted adjusted earnings per share of $0.67, outperforming the consensus estimate of $0.47 by 20 cents. Revenue…
-

Currenc Shares Surge 25% Following Planned Reverse Merger with Animoca Brands
Currenc Group Inc. (NASDAQ:CURR) shares skyrocketed 25% on Monday after the fintech company announced plans for a reverse merger with Animoca Brands Corporation Limited, a global leader in digital assets and blockchain innovation. The deal would create what the two firms describe as “the world’s first publicly listed digital assets conglomerate” on the Nasdaq exchange.…
-

FuboTV Shares Climb as Strong Q3 Results Deliver Profit and Beat Expectations
FuboTV Inc. (NYSE:FUBO) shares rose 5.3% on Monday after the sports-centric streaming platform reported third-quarter results that exceeded Wall Street expectations, including a surprise adjusted profit and higher-than-expected revenue, highlighting its ongoing subscriber momentum. The company posted a loss of $0.06 per share, outperforming analyst projections of a $0.09 loss, while revenue reached $377.2 million,…
-

Alvotech Shares Slide After FDA Requests Further Action on Simponi Biosimilar
Shares of Alvotech (NASDAQ: ALVO) fell 22% on Monday after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company’s proposed biosimilar to Simponi. The FDA stated that deficiencies identified during a pre-license inspection of Alvotech’s Reykjavik, Iceland, manufacturing facility in July 2025 must be addressed before the Biologics…